Skip to main content
OpenTrials
Completed

NCT Number: NCT04075461

Arthroplasty Versus Internal Fixation for Undisplaced Femoral Neck Fracture

This is the world's first national orthopedic randomized controlled trial (RCT) involving 19 out of 21 departments in Denmark. Each year, 7,000 patients suffer a hip fracture. This is a severe condition leading to 25% mortality after 1 year and 40% do not recover to the same functional level. The aim is to compare two surgical treatment methods (metal fixation versus artificial hip) in patients above 65 years with an undisplaced femoral neck fracture. The hypothesis is that even though an artificial hip is a larger surgical procedure than metal fixation of the broken bone, the artificial hip is more stable with less pain due the lack of a healing broken bone and therefore leads to a better and quicker mobilization after surgery. Better mobilization is one of the most important factors for decreasing mortality. We have chosen a pragmatic RCT design by using the local departmental implants. We hope that the knowledge from this study will therefore easily be implemented afterwards.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital of Southern Jutland, Aabenraa, Denmark

Loading trial locations.

About this study

This is the world's first national orthopedic randomized controlled trial (RCT) involving 20 out of 21 departments in Denmark. The aim is to compare two surgical treatment methods (internal fixation (IF) versus arthroplasty) in patients above 65 years with an undisplaced femoral neck fracture (FNF).

Each year, 7,000 patients suffer a hip fracture. This is a severe condition leading to 25% mortality after 1 year and 40% do not recover to the same functional level. Undisplaced FNF is treated with internal fixation in order to aid in fracture healing. However, approximately 10% in Denmark will suffer a reoperation and two RCT's have demonstrated 20-21% reoperations. In comparison, the reoperation frequency was 5-7% for arthroplasty that also demonstrated slightly faster mobilization which is one of the most important factors for decreasing mortality. The hypothesis is therefore that even though arthroplasty is a larger surgery they benefit from the lack of fracture healing, less pain and faster mobilization.

Patients are included in the emergency department and are electronically randomized to either IF or arthroplasty before the surgery. The design is a pragmatic RCT using the implants which are available in the departments. Furthermore, the postoperative treatment protocol is "business as usual" thereby investigating the precise effect of the intervention in real clinical conditions. In addition to a great external validity this allows for easy implemented after study results. The primary outcome is a validated functional score 1 year after surgery and the sample size is calculated to 330 patients. Secondary outcome measures are additional functional assessments and questionnaires, health related quality of life and pain assessment.

We have set up a steering committee consisting of researchers and senior surgeons with a representative from each region. In addition, all but 1 hospital has a representative in project group. The project is therefore anchored in the entire Denmark.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 65 years old
  • Undisplaced femoral neck fracture
  • Posterior tilt (18) less than 20 degrees
  • NMS (13) = 5 and above, indicating an ability to walk
  • Cognitive intact in order to achieve informed consent

Exclusion criteria

  • The fracture is pathological
  • The patient does not speak Danish

Treatment and study plan

Arthroplasty

Procedure

Arthroplasty is commonly used for a displaced femoral neck fracture.

Internal fixation

Procedure

Internal fixation is commonly used for undisplaced femoral neck fracture

Primary outcomes

  1. New Mobility Score (NMS)

    Time frame: 12 months

    NMS score the level of function with a score from 0-9 points. The best score is 9 points.

Secondary outcomes

  1. EuroQol 5 domain 5 level (EQ-5D-5L)

    Time frame: Admission, 3 months, 6 months and 12 months.

    Health related quality of life assessment with a score from 0-1 point. The best score is 1 point

  2. Oxford Hip Score (OHS)

    Time frame: Admission, 3 months, 6 months and 12 months.

    Specific hip function questionnaire with a score from 0-48 points. The best score is 48 points.

  3. Reoperation

    Time frame: Within 1 year after surgery

    New surgery in relation to the primary surgery

  4. Mortality

    Time frame: Within 1 year after surgery

    Mortality

  5. New Mobility Score (NMS)

    Time frame: Admission, 3 and 6 months

    NMS score the level of function with a score from 0-9 points. The best score is 9 points.

  6. Pain Verbal Rating Scale (VRS)

    Time frame: Admission, 2 and 6 weeks, 3, 6, and 12 months

    Patient reported outcome of pain assessment

Other outcomes

  1. New Mobility Score (NMS)

    Time frame: 2 and 5 years

    NMS score the level of function with a score from 0-9 points. The best score is 9 points.

  2. EuroQol 5 domain 5 level (EQ-5D-5L)

    Time frame: 2 and 5 years

    Health related quality of life assessment with a score from 0-1 point. The best score is 1

  3. Reoperation

    Time frame: 2 and 5 years

    New surgery in relation to the primary surgery, given in numbers and percentage

  4. Mortality

    Time frame: 2 and 5 years

    Mortality given in number of deaths and percentage

  5. Pain Verbal Rating Scale (VRS)

    Time frame: 2 and 5 years

    Patient reported outcome of pain assessment of pain from 1 to 10

  6. Oxford Hip Score (OHS)

    Time frame: 2 and 5 years

    Specific hip function questionnaire with a score from 0-48 points. The best score is 48 points.

  7. de Morton Mobility Index (DEMMI)

    Time frame: Admission, 3 months, 6 months, 12 months, 2 and 5 years

    Mobility index with a score from 0-100 points. The best score is 100 points

  8. Barthel-20

    Time frame: Admission, 3 months, 6 months, 12 months, 2 and 5 years

    Index for activities of daily living with a score from 0-20 points. The best score is 20 points.

  9. Cumulated Cumulated Ambulation Score (CAS)

    Time frame: Admission, 6 and 12 weeks

    Basic mobility score with a score from 0-6 points. The best score is 6 points.

  10. X-ray measurement 1

    Time frame: First postoperative x-ray during admission and 1 year

    Quality of implant positioning (IMPO) score with a score from 0-6 point. The best score is 6 points

Sponsors and collaborators

Lead sponsor

University of Southern Denmark

Other

Collaborators

  • Aalborg University Hospital
  • Aarhus University Hospital
  • Bispebjerg Hospital
  • Bornholm Hospital
  • Esbjerg Hospital - University Hospital of Southern Denmark
  • Herlev Hospital
  • Hillerod Hospital, Denmark
  • Holbaek Sygehus
  • Hospital of Southern Jutland
  • Hvidovre University Hospital
  • Nykøbing Falster County Hospital
  • Odense University Hospital
  • Randers Regional Hospital
  • Regional Hospital West Jutland
  • Regionshospital Nordjylland
  • Regionshospitalet Horsens
  • Regionshospitalet Viborg, Skive
  • Slagelse Hospital
  • Sygehus Lillebaelt
  • Zealand University Hospital

Registry information

Official study title

Is arthroplaSty bEtter Than interNal Fixation in the undiSplaced Femoral nEck Fracture? A National Pragmatical Randomized Controlled Trial - the SENSE Trial

Acronym: SENSE

Important dates

Study start
2020
Primary completion
2024
Study completion
2025
First posted
Aug 30, 2019
Registry last updated
Mar 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.